Vesicular stomatitis virus: An exciting new therapeutic oncolytic virus candidate for cancer or just another chapter from Field's Virology?
- 31 October 2003
- journal article
- review article
- Published by Elsevier BV in Cancer Cell
- Vol. 4 (4), 241-243
- https://doi.org/10.1016/s1535-6108(03)00251-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Oncolysis of hepatic metastasis of colorectal cancer by recombinant vesicular stomatitis virus in immune-competent miceMolecular Therapy, 2003
- Development of Recombinant Vesicular Stomatitis Viruses That Exploit Defects in Host Defense To Augment Specific Oncolytic ActivityJournal of Virology, 2003
- RNA viruses as virotherapy agentsCancer Gene Therapy, 2002
- Innate recognition of bacteria by a macrophage cytosolic surveillance pathwayProceedings of the National Academy of Sciences, 2002
- Replication-selective virotherapy for cancer: Biological principles, risk management and future directionsNature Medicine, 2001
- Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cellsVirus Research, 2001
- The Matrix Protein of Vesicular Stomatitis Virus Inhibits Nucleocytoplasmic Transport When It Is in the Nucleus and Associated with Nuclear Pore ComplexesMolecular and Cellular Biology, 2000
- VSV-G Pseudotyped Lentiviral Vector Particles Produced in Human Cells Are Inactivated by Human SerumMolecular Therapy, 2000
- Vesicular Stomatitis Virus (VSV) Therapy of TumorsIUBMB Life, 2000
- Essential Role for the dsRNA-Dependent Protein Kinase PKR in Innate Immunity to Viral InfectionImmunity, 2000